These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39006722)

  • 21. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine.
    Chatterjee SS; Mitra S; Mallik N
    Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):316-8. PubMed ID: 26598592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case with euprolactinemic galactorrhea induced by escitalopram.
    Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
    Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants induce toxicity in human placental BeWo cells.
    Nabekura T; Ishikawa S; Tanase M; Okumura T; Kawasaki T
    Curr Res Toxicol; 2022; 3():100073. PubMed ID: 35602006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review.
    Marasine NR; Sankhi S; Lamichhane R; Marasini NR; Dangi NB
    Biomed Res Int; 2021; 2021():6699028. PubMed ID: 33791379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
    Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
    BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
    Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
    Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.
    Nurnberg HG; Thompson PM; Hensley PL
    J Clin Psychiatry; 1999 Sep; 60(9):574-9. PubMed ID: 10520974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of sertraline on routine blood chemistry values.
    Catalano MC; Catalano G; Kanfer SN; Toner LC; Stock SL; Taylor WD
    Clin Neuropharmacol; 2000; 23(5):267-70. PubMed ID: 11154094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of two assessment tools of antidepressant side-effects: UKU scale versus spontaneous notification].
    Gruwez B; Gury C; Poirier MF; Bouvet O; Gérard A; Bourdel MC; Baylé FJ; Olié JP
    Encephale; 2004; 30(5):425-32. PubMed ID: 15627047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.
    Damsa C; Bumb A; Bianchi-Demicheli F; Vidailhet P; Sterck R; Andreoli A; Beyenburg S
    J Clin Psychiatry; 2004 Aug; 65(8):1064-8. PubMed ID: 15323590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hair Loss Associated with Paroxetine Use: A Case Report.
    Kurhan F; Kamış GZ
    Turk Psikiyatri Derg; 2021; 32(1):61-64. PubMed ID: 34181746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Data on SSRI Antidepressant Side Effects.
    Cascade E; Kalali AH; Kennedy SH
    Psychiatry (Edgmont); 2009 Feb; 6(2):16-8. PubMed ID: 19724743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitor exposure.
    Fitzgerald KT; Bronstein AC
    Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.
    Kishimoto A; Todani A; Miura J; Kitagaki T; Hashimoto K
    Ann Gen Psychiatry; 2010 May; 9():23. PubMed ID: 20492642
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.